Given the significant role of NIH in supporting health research in US universities, the Trump Administrations proposed 20% cuts in NIH funding may result in :
1) Less support for developing life-saving disease treatments.
2) Reduced funding options for emerging companies.
3) Fewer bioscience jobs
This document summarizes Senator Barack Obama's health policy plan, which focuses on achieving universal health care coverage, health care reform, and strengthening public health. It outlines some of the key problems in the current US healthcare system from the perspectives of providers, purchasers, and consumers. Obama's plan would invest in health information technology and reform reimbursement to align with quality. The plan is estimated to cost $50-65 billion annually but could save $120-200 billion through reduced administrative costs, improved disease management, and health IT savings. If implemented, it could lower family insurance costs by $2,500 and cover 10 million more people.
A Value Proposition for Creating Crowdfunding Research Platform for Integrati...Joanne Sienko Ott, CFA, MA
?
A value proposition exists at the intersection of two innovations - IM clinical practice and a crowdfunding research platform C at this nexus arises the potential solutions to address the U.S. healthcare Triple AIM: better care, better outcomes, lower costs. Crowdfunding is a socially mediated phenomenon based on intrinsic trust individuals place on shared connections and a willingness to fund projects or causes based on passion alone. What gets funded is what strikes a chord with funders. The passage of the 2012 JOBS Act has resulted in a flood of crowdfunding platforms that have raised over $5.1 billion. Crowdfunding is being utilized for medical research. Health philanthropists and impact investors are collaborating in new ways to make a bigger impact and build capacity, however they want to see buy-in before taking on risk. Crowdfunding mechanisms provide an automatic feedback loop for concepts and give indication of risk prior to investor venture. At the other side of this nexus a crippling healthcare system has produced lower outcomes/higher costs fast approaching 20% of GDP. Evidence suggests that IM practices is effective and could ease the pain in our healthcare system. Barriers exist for clinical practice of IM, based on lack of sufficient evidence and funded research. NCCIHs portion of the total NIH budget remains at less than 1% and PCORI is not focused on comparative studies of conventional interventions with IM in seeking better outcomes. Creating a crowdfunding research platform is an intriguing proposition that could engage mindful investment in research methodology for IM clinical practices. At this nexus C a crowdfunding IM/CAM research platform - all those who are passionate about a healthcare system that promotes health creation and treats the whole person through holistic approaches that optimize healing, could be funders such as philanthropists, impact investors, patients, and practitioners alike.
Intelligent Buildings can use the skills of the control experts in the process field like the ISA Chapter members. Recent IEC Standard on cybersecurity is applicable to the building automation field.
This is the presentation slide deck for my 45 minute talk at TriAgile; it discusses how anyone can lead change and gives some techniques that can be used.
This document provides an overview of the February 2017 issue of the SAMENA Trends newsletter, which is exclusively for SAMENA Telecommunications Council members. The issue features an editorial on redefining data rules for a data-driven business environment. It also includes featured interviews, regional and member updates, technology updates, regulatory updates, and summaries of SAMENA Council activities. The interviews discuss Etisalat's investments in infrastructure to support 5G and digital transformation initiatives. Regional updates announce that STC's brand value increased 11% to become the most valuable brand in Saudi Arabia and the Middle East.
Convite para dois workshops no ?mbito do projeto Erasmus+ "Inovar Prticas, Abrir Horizontes" sobre Peer Coaching e gest?o de conflitos na sala de aula, a realizar em 19 de abril com inscri??es online ou impressas nas escolas e dinamizados por dois grupos de formadoras.
This document provides an overview of microservices, including:
- What microservices are and how they differ from monolithic architectures and SOA.
- Common microservice design patterns like aggregator, proxy, chained, and asynchronous messaging.
- Operational challenges of microservices like infrastructure, load balancing, monitoring.
- How microservices compare to SOA in terms of independence, scalability, and technology diversity.
- Key security considerations for microservices related to network access, authentication, and operational complexity.
This document provides a three-step strategy for enhancing career competency and securing a dream job or internship:
Step 1) Develop key skills by learning programming languages, digital and analog circuits skills, and implementing projects.
Step 2) Prove your skills by competing in various competitions for internships, cash prizes, and project incubation.
Step 3) Get a dream internship or job by applying directly on company career portals, connecting with professionals, achieving high scores on placement tests, or securing research internships at universities.
IoF2020 project overview for BDE/eRosa/GODANSjaak Wolfert
?
Presentation of the IoF2020 project at the 2nd Joint workshop of Big Data Europe, eRosa & GODAN on European Policy Perspectives on Data-intensive Agriculture & Food.
Dr. Alan Bernstein, president of the Canadian Institutes of Health Research (CIHR), has set an ambitious goal to turn Canada's $20 billion annual healthcare spending into a research-driven enterprise to capture both health and economic benefits. Under Bernstein's leadership, the CIHR has increased funding for healthcare research significantly, focusing on areas like health services research and population health that have the potential to improve healthcare delivery and identify preventative strategies. The CIHR also aims to commercialize research discoveries in Canada in order to fund new research, reward scientists, and retain top talent in the country. Several examples are provided of research institutions and startups that have successfully commercialized healthcare technologies and therapies with support from the CIHR.
?AACR Press Release Early-Career Hill DayMario Pulido
?
The American Association for Cancer Research (AACR) sent 15 early-career cancer scientists to Capitol Hill for their inaugural Early-career Hill Day. These scientists met with 36 congressional members and staff to discuss how early-career scientists have been disproportionately affected by stagnant funding from the National Institutes of Health and National Cancer Institute over the past decade, making it harder to obtain grants and remain in research careers. The AACR is working to support early-career investigators and help secure continued funding growth through initiatives like new grants for young researchers.
The document summarizes California's strong biomedical industry in 2015. It notes that California leads the nation in biomedical research and development, supporting over 270,000 high-paying jobs. The state's world-class universities and research institutions attract billions in funding each year to advance scientific discovery and develop new medicines and technologies. California's biomedical sector had $101 billion in revenues in 2013 and continues to be an economic driver in the state.
Research!America President Mary Woolley's presentation to the Board of Trustees of the Association for Research in Vision and Ophthalmology. Washington, DC, October 29, 2009.
The document introduces the All of Us Research Program, which aims to collect health data from one million Americans to advance precision medicine research. It was announced by President Obama in 2015. The program receives funding from the federal government and private partners. It collects various types of health data from participants through surveys, health records, samples, and devices. The data is stored and shared securely while protecting privacy. The goal is to generate new medical discoveries and more personalized healthcare through collaboration between researchers and participants.
The document discusses innovation in cancer treatment in California. It notes that California companies have hundreds of oncology products in development that could lead to new lifesaving therapies. Continued investment is critical to ongoing research and development of new treatments. The pace of innovation has quickened in recent years, with 29 new cancer treatments approved nationally since 2008 alone.
Driving Breakthroughs In Healthcare - The Impact Of Federal Funding For Medic...Americas Got Grants
?
Federal funding for medical research serves as a crucial lifeline, providing the financial resources necessary for scientists to undertake comprehensive and reliable studies. Without consistent support, researchers risk abandoning promising projects before they can achieve meaningful results. Platforms like Grants.gov, which consolidates grant opportunities from various federal agencies.
Enduring Hearts is a non-profit organization that funds research to increase the longevity of pediatric heart transplants. Their mission is to fund clinical research projects and emerging technologies focusing on organ rejection and deterioration. Key facts include that 1 in 4 children needing a repeat heart transplant within 5 years, and over 4,000 people are on the waiting list for heart transplants with 150 needing a repeat. Enduring Hearts funds multiple research projects each year at universities around the world through individual donations and partnerships with other organizations. Their goal is to improve quality of life for transplant recipients through innovative research.
NIH Research grants (R series) are an important funding mechanism for independent investigators as these awards offer the opportunity to head up major research projects.
In this presentation, Dr. Ian de Boer will leverage his experience from winning six different R awards to provide R series grant writing strategies. He explores: which R award is best for you; readiness and qualifications for independent support; formulating focused and solid research strategies; how to avoid common mistakes; tips for early investigators; and NIH expectations and grant requirements.
Tips for new and early-career researchers for navigating the NIH funding system. Addresses common mistakes, misconceptions, and things for researchers to think about when choosing grant mechanisms, and preparing to submit a grant proposal to NIH.
The newsletter provides updates on the Department of Community and Family Medicine at Duke University. Key points include:
- Duke received $699.5 million from NIH to establish the Duke Translational Science Institute, with Lloyd Michener appointed director of the Duke Center for Community Research pillar.
- Peggy Riley Robinson, a faculty member in the PA program, was appointed to the North Carolina Medical Board.
- Robert Richardson received the Association of Rheumatology Health Professionals' Lifetime Achievement Award.
The annual report summarizes Research to Prevent Blindness' (RPB) activities and grants in 2014. It provides an overview of RPB leadership including the Chairman, President, Board of Trustees, and officers. It also highlights some of the impactful research advances that were supported by RPB grants that year, including studies on omega-3 fatty acids for age-related macular degeneration, a gel to reduce cataracts after surgery, an oral treatment for uveitis, the benefits of exercise for retinal health, and using the eye to study other diseases. The report discusses RPB's role in convening vision research funders to foster collaboration and addresses how RPB is addressing the major needs and opportunities in vision research
The annual report summarizes Research to Prevent Blindness' (RPB) activities and grants in 2014. It provides an overview of RPB leadership including the Chairman, President, Board of Trustees, and officers. It also highlights some of the impactful research advances that RPB funded in 2014, including studies on omega-3 fatty acids and age-related macular degeneration, a gel to reduce cataracts after surgery, an oral treatment for uveitis, the benefits of exercise on eye health, and using the eye to study other diseases. Additionally, it describes RPB's role in convening vision research organizations to foster collaboration and partnership to accelerate solutions for vision loss.
Crowdfunding for medical research picks up pace.pdfJichaoChen2
?
Crowdfunding for medical research is gaining popularity as a way to raise funds for projects that may not receive traditional sources of funding. Several researchers have turned to crowdfunding sites with success, raising thousands of dollars from public donations for projects. However, some concerns remain that only "sexy" projects about animals may attract funds, and that peer review is still needed to vet projects. As government research funding declines, crowdfunding may continue growing as a way for young researchers to obtain seed funding, but growing the infrastructure and vetting process will be important for it to reach larger scales of funding.
Convite para dois workshops no ?mbito do projeto Erasmus+ "Inovar Prticas, Abrir Horizontes" sobre Peer Coaching e gest?o de conflitos na sala de aula, a realizar em 19 de abril com inscri??es online ou impressas nas escolas e dinamizados por dois grupos de formadoras.
This document provides an overview of microservices, including:
- What microservices are and how they differ from monolithic architectures and SOA.
- Common microservice design patterns like aggregator, proxy, chained, and asynchronous messaging.
- Operational challenges of microservices like infrastructure, load balancing, monitoring.
- How microservices compare to SOA in terms of independence, scalability, and technology diversity.
- Key security considerations for microservices related to network access, authentication, and operational complexity.
This document provides a three-step strategy for enhancing career competency and securing a dream job or internship:
Step 1) Develop key skills by learning programming languages, digital and analog circuits skills, and implementing projects.
Step 2) Prove your skills by competing in various competitions for internships, cash prizes, and project incubation.
Step 3) Get a dream internship or job by applying directly on company career portals, connecting with professionals, achieving high scores on placement tests, or securing research internships at universities.
IoF2020 project overview for BDE/eRosa/GODANSjaak Wolfert
?
Presentation of the IoF2020 project at the 2nd Joint workshop of Big Data Europe, eRosa & GODAN on European Policy Perspectives on Data-intensive Agriculture & Food.
Dr. Alan Bernstein, president of the Canadian Institutes of Health Research (CIHR), has set an ambitious goal to turn Canada's $20 billion annual healthcare spending into a research-driven enterprise to capture both health and economic benefits. Under Bernstein's leadership, the CIHR has increased funding for healthcare research significantly, focusing on areas like health services research and population health that have the potential to improve healthcare delivery and identify preventative strategies. The CIHR also aims to commercialize research discoveries in Canada in order to fund new research, reward scientists, and retain top talent in the country. Several examples are provided of research institutions and startups that have successfully commercialized healthcare technologies and therapies with support from the CIHR.
?AACR Press Release Early-Career Hill DayMario Pulido
?
The American Association for Cancer Research (AACR) sent 15 early-career cancer scientists to Capitol Hill for their inaugural Early-career Hill Day. These scientists met with 36 congressional members and staff to discuss how early-career scientists have been disproportionately affected by stagnant funding from the National Institutes of Health and National Cancer Institute over the past decade, making it harder to obtain grants and remain in research careers. The AACR is working to support early-career investigators and help secure continued funding growth through initiatives like new grants for young researchers.
The document summarizes California's strong biomedical industry in 2015. It notes that California leads the nation in biomedical research and development, supporting over 270,000 high-paying jobs. The state's world-class universities and research institutions attract billions in funding each year to advance scientific discovery and develop new medicines and technologies. California's biomedical sector had $101 billion in revenues in 2013 and continues to be an economic driver in the state.
Research!America President Mary Woolley's presentation to the Board of Trustees of the Association for Research in Vision and Ophthalmology. Washington, DC, October 29, 2009.
The document introduces the All of Us Research Program, which aims to collect health data from one million Americans to advance precision medicine research. It was announced by President Obama in 2015. The program receives funding from the federal government and private partners. It collects various types of health data from participants through surveys, health records, samples, and devices. The data is stored and shared securely while protecting privacy. The goal is to generate new medical discoveries and more personalized healthcare through collaboration between researchers and participants.
The document discusses innovation in cancer treatment in California. It notes that California companies have hundreds of oncology products in development that could lead to new lifesaving therapies. Continued investment is critical to ongoing research and development of new treatments. The pace of innovation has quickened in recent years, with 29 new cancer treatments approved nationally since 2008 alone.
Driving Breakthroughs In Healthcare - The Impact Of Federal Funding For Medic...Americas Got Grants
?
Federal funding for medical research serves as a crucial lifeline, providing the financial resources necessary for scientists to undertake comprehensive and reliable studies. Without consistent support, researchers risk abandoning promising projects before they can achieve meaningful results. Platforms like Grants.gov, which consolidates grant opportunities from various federal agencies.
Enduring Hearts is a non-profit organization that funds research to increase the longevity of pediatric heart transplants. Their mission is to fund clinical research projects and emerging technologies focusing on organ rejection and deterioration. Key facts include that 1 in 4 children needing a repeat heart transplant within 5 years, and over 4,000 people are on the waiting list for heart transplants with 150 needing a repeat. Enduring Hearts funds multiple research projects each year at universities around the world through individual donations and partnerships with other organizations. Their goal is to improve quality of life for transplant recipients through innovative research.
NIH Research grants (R series) are an important funding mechanism for independent investigators as these awards offer the opportunity to head up major research projects.
In this presentation, Dr. Ian de Boer will leverage his experience from winning six different R awards to provide R series grant writing strategies. He explores: which R award is best for you; readiness and qualifications for independent support; formulating focused and solid research strategies; how to avoid common mistakes; tips for early investigators; and NIH expectations and grant requirements.
Tips for new and early-career researchers for navigating the NIH funding system. Addresses common mistakes, misconceptions, and things for researchers to think about when choosing grant mechanisms, and preparing to submit a grant proposal to NIH.
The newsletter provides updates on the Department of Community and Family Medicine at Duke University. Key points include:
- Duke received $699.5 million from NIH to establish the Duke Translational Science Institute, with Lloyd Michener appointed director of the Duke Center for Community Research pillar.
- Peggy Riley Robinson, a faculty member in the PA program, was appointed to the North Carolina Medical Board.
- Robert Richardson received the Association of Rheumatology Health Professionals' Lifetime Achievement Award.
The annual report summarizes Research to Prevent Blindness' (RPB) activities and grants in 2014. It provides an overview of RPB leadership including the Chairman, President, Board of Trustees, and officers. It also highlights some of the impactful research advances that were supported by RPB grants that year, including studies on omega-3 fatty acids for age-related macular degeneration, a gel to reduce cataracts after surgery, an oral treatment for uveitis, the benefits of exercise for retinal health, and using the eye to study other diseases. The report discusses RPB's role in convening vision research funders to foster collaboration and addresses how RPB is addressing the major needs and opportunities in vision research
The annual report summarizes Research to Prevent Blindness' (RPB) activities and grants in 2014. It provides an overview of RPB leadership including the Chairman, President, Board of Trustees, and officers. It also highlights some of the impactful research advances that RPB funded in 2014, including studies on omega-3 fatty acids and age-related macular degeneration, a gel to reduce cataracts after surgery, an oral treatment for uveitis, the benefits of exercise on eye health, and using the eye to study other diseases. Additionally, it describes RPB's role in convening vision research organizations to foster collaboration and partnership to accelerate solutions for vision loss.
Crowdfunding for medical research picks up pace.pdfJichaoChen2
?
Crowdfunding for medical research is gaining popularity as a way to raise funds for projects that may not receive traditional sources of funding. Several researchers have turned to crowdfunding sites with success, raising thousands of dollars from public donations for projects. However, some concerns remain that only "sexy" projects about animals may attract funds, and that peer review is still needed to vet projects. As government research funding declines, crowdfunding may continue growing as a way for young researchers to obtain seed funding, but growing the infrastructure and vetting process will be important for it to reach larger scales of funding.
5 presentations on the challenges and options for science funding (health research) in Canada from a panel at the Canadian Science Policy Conference, 2013. Presenters: Christine Williams, Peter Goodhand, Jane Aubin, Phil Hieter and Jim Woodgett (chair).
FasterCures Presentation: Fostering innovation while delivering treatments an...TRAIN Central Station
?
FasterCures' Margaret Anderson presents at the 2009 BioEconomy Summit Healthcare Policy Session 2: Affordability and Access. Presents new business models to accelerate research.
LLS Southern California Blood Cancer Conference, March 4, 2017Jerry Lee
?
Jerry S.H. Lee, Ph.D. is the Health Sciences Director and Deputy Director of the Center for Strategic Scientific Initiatives (CSSI) at the National Cancer Institute (NCI). He discussed advancing innovation and convergence in cancer research. Key points included:
- CSSI's role in creating exploratory programs to accelerate cancer data sharing and tool development.
- Progress made by The Cancer Genome Atlas (TCGA) in collecting and analyzing tumor samples to discover new cancer subtypes and therapeutic targets.
- Importance of data quality, standardization, and sharing enabled by initiatives like TCGA to generate new insights into cancer biology.
- Continued momentum in 2017 to leverage data from initiatives like
Federal funding for biomedical research has declined significantly in recent years due to budget constraints. This threatens scientific progress and the development of new treatments. Industry and universities must explore new collaborations to supplement decreased government funding. Innovative public-private partnerships and new funding models are needed to sustain world-class biomedical research and innovation in the US.
The document discusses the Intensive Care Foundation (ICF), which coordinates over 70% of UK intensive care research. The ICF was established 10 years ago by the Intensive Care Society (ICS) to promote critical care study and research. While the ICS currently provides most funding, the ICF's long-term focus is becoming self-funded through diverse income streams like other medical charities. The ICF has established an important role in the critical care community by funding quality research projects through a competitive peer review process.
Creatines Untold Story and How 30-Year-Old Lessons Can Shape the FutureSteve Jennings
?
Creatine burst into the public consciousness in 1992 when an investigative reporter inside the Olympic Village in Barcelona caught wind of British athletes using a product called Ergomax C150. This led to an explosion of interest in C and questions about C the ingredient after high-profile British athletes won multiple gold medals.
I developed Ergomax C150, working closely with the late and great Dr. Roger Harris (1944 2024), and Prof. Erik Hultman (1925 2011), the pioneering scientists behind the landmark studies of creatine and athletic performance in the early 1990s.
Thirty years on, these are the slides I used at the Sports & Active Nutrition Summit 2025 to share the story, the lessons from that time, and how and why creatine will play a pivotal role in tomorrows high-growth active nutrition and healthspan categories.
At Macafem, we provide 100% natural support for women navigating menopause. For over 20 years, we've helped women manage symptoms, and in 2024, we're proud to share their heartfelt experiences.
Cardiac Arrhythmia definition, classification, normal sinus rhythm, characteristics , types and management with medical ,surgical & nursing, health education and nursing diagnosis for paramedical students.
Title: Regulation of Tubular Reabsorption C A Comprehensive Overview
Description:
This lecture provides a detailed and structured explanation of the mechanisms regulating tubular reabsorption in the kidneys. It explores how different physiological and hormonal factors influence glomerular filtration and reabsorption rates, ensuring fluid and electrolyte balance in the body.
? Who Should Read This?
This presentation is designed for:
?? Medical Students (MBBS, BDS, Nursing, Allied Health Sciences) preparing for physiology exams.
?? Medical Educators & Professors looking for structured teaching material.
?? Healthcare Professionals (doctors, nephrologists, and physiologists) seeking a refresher on renal physiology.
?? Postgraduate Students & Researchers in the field of medical sciences and physiology.
? What Youll Learn:
? Local Regulation of Tubular Reabsorption
?? Glomerulo-Tubular Balance C its mechanism and clinical significance
?? Net reabsorptive forces affecting peritubular capillaries
?? Role of peritubular hydrostatic and colloid osmotic pressures
? Hormonal Regulation of Tubular Reabsorption
?? Effects of Aldosterone, Angiotensin II, ADH, and Natriuretic Peptides
?? Clinical conditions like Addisons disease & Conn Syndrome
?? Mechanisms of pressure natriuresis and diuresis
? Nervous System Regulation
?? Sympathetic Nervous System activation and its effects on sodium reabsorption
? Clinical Correlations & Case Discussions
?? How renal regulation is altered in hypertension, hypotension, and proteinuria
?? Comparison of Glomerulo-Tubular Balance vs. Tubulo-Glomerular Feedback
This presentation provides detailed diagrams, flowcharts, and calculations to enhance understanding and retention. Whether you are studying, teaching, or practicing medicine, this lecture will serve as a valuable resource for mastering renal physiology.
? Keywords for Easy Search:
#Physiology #RenalPhysiology #TubularReabsorption #GlomeruloTubularBalance #HormonalRegulation #MedicalEducation #Nephrology
1. Explain the physiological control of glomerular filtration and renal blood flow
2. Describe the humoral and autoregulatory feedback mechanisms that mediate the autoregulation of renal plasma flow and glomerular filtration rate
Solubilization in Pharmaceutical Sciences: Concepts, Mechanisms & Enhancement...KHUSHAL CHAVAN
?
This presentation provides an in-depth understanding of solubilization and its critical role in pharmaceutical formulations. It covers:
Definition & Mechanisms of Solubilization
Role of surfactants, micelles, and bile salts in drug solubility
Factors affecting solubilization (pH, polarity, particle size, temperature, etc.)
Methods to enhance drug solubility (Buffers, Co-solvents, Surfactants, Complexation, Solid Dispersions)
Advanced approaches (Polymorphism, Salt Formation, Co-crystallization, Prodrugs)
This resource is valuable for pharmaceutical scientists, formulation experts, regulatory professionals, and students interested in improving drug solubility and bioavailability.
Best Sampling Practices Webinar C USP <797> Compliance & Environmental Monito...NuAire
?
Best Sampling Practices Webinar C USP <797> Compliance & Environmental Monitoring
Are your cleanroom sampling practices USP <797> compliant? This webinar, hosted by Pharmacy Purchasing & Products (PP&P Magazine) and sponsored by NuAire, features microbiology expert Abby Roth discussing best practices for surface & air sampling, data analysis, and compliance.
? Key Topics Covered:
?? Viable air & surface sampling best practices
?? USP <797> requirements & compliance strategies
?? How to analyze & trend viable sample data
?? Improving environmental monitoring in cleanrooms
? Watch Now: https://www.nuaire.com/resources/best-sampling-practices-cleanroom-usp-797
? Stay informedfollow Abby Roth on LinkedIn for more cleanroom insights!
Dr. Anik Roy Chowdhury
MBBS, BCS(Health), DA, MD (Resident)
Department of Anesthesiology, ICU & Pain Medicine
Shaheed Suhrawardy Medical College Hospital (ShSMCH)
Flag Screening in Physiotherapy Examination.pptxBALAJI SOMA
?
Flag screening is a crucial part of physiotherapy assessment that helps in identifying medical, psychological, occupational, and social barriers to recovery. Recognizing these flags ensures that physiotherapists make informed decisions, provide holistic care, and refer patients appropriately when necessary. By integrating flag screening into practice, physiotherapists can optimize patient outcomes and prevent chronicity of conditions.
Acute & Chronic Inflammation, Chemical mediators in Inflammation and Wound he...Ganapathi Vankudoth
?
A complete information of Inflammation, it includes types of Inflammation, purpose of Inflammation, pathogenesis of acute inflammation, chemical mediators in inflammation, types of chronic inflammation, wound healing and Inflammation in skin repair, phases of wound healing, factors influencing wound healing and types of wound healing.
Presentaci que va acompanyar la demostraci prctica de metge d'Innovaci Jos Ferrer sobre el projecte Benestar de BSA, nom d'IDIAP Pere Gol, el 5 de mar? de 2025 a l'estand de XarSMART al Mobible Word Congress.
legal Rights of individual, children and women.pptxRishika Rawat
?
A legal right is a claim or entitlement that is recognized and protected by the law. It can also refer to the power or privilege that the law grants to a person. Human rights include the right to life and liberty, freedom from slavery and torture, freedom of opinion and expression, the right to work and education
Stability of Dosage Forms as per ICH GuidelinesKHUSHAL CHAVAN
?
This presentation covers the stability testing of pharmaceutical dosage forms according to ICH guidelines (Q1A-Q1F). It explains the definition of stability, various testing protocols, storage conditions, and evaluation criteria required for regulatory submissions. Key topics include stress testing, container closure systems, stability commitment, and photostability testing. The guidelines ensure that pharmaceutical products maintain their identity, purity, strength, and efficacy throughout their shelf life. This resource is valuable for pharmaceutical professionals, researchers, and regulatory experts.
Stability of Dosage Forms as per ICH GuidelinesKHUSHAL CHAVAN
?
NIH Support of Health Research in California
1. NIH SUPPORT OF HEALTH RESEARCH
IN THE STATE OF CALIFORNIA
The Proposed 20% Cuts in NIH Budget May Put
Health Research and Jobs at Risk
Ahmed Enany
President & CEO
SoCalBio
2. C 2017 SoCalBio
OVERVIEW
? Given the significant role of NIH in supporting health research in
US universities, the Trump Administrations proposed 20% cuts in
NIH funding may result in :
? Less support for developing life-saving disease treatments.
? Reduced funding options for emerging companies.
? Fewer bioscience jobs.
? In 2016, NIH allocated $24.83 billion -- out of a $32 billion total
budget -- in extramural research grants.
? With $3.7 billion or 15% of NIH extramural grants, California was
the leading recipient of such funding:
? 5,067 researchers in 416 California organizations were funded.
? The bulk of the funding supports basic and applied research at non-
profit educational institutions and research hospitals:
? UCSF, Stanford U., UCSD, UCLA and Scripps are the top five California organizations
attracting $578 million, $427 million, $401 million, $381 million, and $214 million of
NIH award funding respectively.
? NIH funding in the form of SBIRs and STTRS supports emerging
bioscience companies:
? In 2016, California attracted one of every five dollars ($176 million out
of $812 million) awarded by the NIH in the form of SBIR or STTR grants.
3/22/2017
2
3. C 2017 SoCalBio
IN 2016, NIH ALLOCATED $24.83 BILLION -- OUT OF A
$32 BILLION TOTAL BUDGET -- IN EXTRAMURAL
RESEARCH GRANTS
? These grants supported:
? 49,013 U.S. research projects.
? 33,663 principal investigators.
? 2,382 Universities, research
hospitals, emerging small
companies engaged in health
R&D.
? The NIH also allocated
$191.72 million to 480 foreign
projects.
? The majority was submitted by
Canadian and European
investigators
3/22/2017
3
Institute Awards
Funding
$Billion
NIAID 5,254 $3.07
NCI 6,575 $2.94
NHLBI 4,804 $2.45
NIGMS 5,800 $2.32
NIDDK 3,812 $1.54
NINDS 3,716 $1.35
NIA 2,224 $1.25
NIMH 2,872 $1.19
NICHD 2,265 $1.04
NIDA 1,934 $0.82
NCATS 286 $0.55
2016 Top Funding Source
4. C 2017 SoCalBio
CALIFORNIA GETS MORE NIH FUNDING THAN ANY OTHER STATE
3/22/2017
4
3.69
2.57
2.2
1.57 1.46
1.15 1.09
0.952
0.818 0.734
0
0.5
1
1.5
2
2.5
3
3.5
4
CA MA NY PA MD NC TX WA IL OH
2016NIHFunding
$Billion
5. C 2017 SoCalBio
THE BULK OF NIH FUNDING SUPPORTS RESEARCH AT
UNIVERSITIES AND RESEARCH HOSPITALS
SMALL ALLOCATIONS ARE MADE TO EMERGING COMPANIES IN THE FORM
OF SBIRS AND STTRS
Funding Mechanism CA Awards CA Funding All Funding CAs Share
RPGs - Non
SBIR/STTR
5,203 $2,598,594,751 $17,137,570,924 15%
RPGs - SBIR/STTR 381 $176,136,281 $812,043,011 22%
Research Centers 240 $385,624,782 $2,642,933,069 15%
Other Research-
Related
948 $295,184,972 $2,091,322,495 14%
R&D Contracts 137 $91,438,716 $1,291,136,757 7%
Training - Individual 518 $24,486,544 $147,564,878 17%
Training -
Institutional
287 $102,836,487 $636,914,717 16%
Other 6 $11,724,056 $73,243,401 16%
Total 7,720 $3,686,026,589 $24,832,729,252 15%
3/22/2017
5
ResearchAllocations
6. C 2017 SoCalBio
THE LOCATION OF 416 CALIFORNIA ORGANIZATIONS
THAT WON $3.7 BILLION IN NIH FUNDING IN 2016
3/22/2017
6
Greater Los Angeles Region
132 Organizations Attracted
$1.087 Billion
San Diego County
102 Organizations Attracted
$850 Million
San Francisco Bay Area
160 Organizations Attracted
$1.497 Billion
Regional Allocations
Other CA
22 Organizations Attracted
$249.88 Million
7. C 2017 SoCalBio
SAN FRANCISCO BAY AREA ORGANIZATIONS THAT WON
NIH GRANTS IN 2016
ORGANIZATION AWARDS
FUNDING
$Million
1 UCSF 1208 577.57
2 STANFORD UNIV. 944 427.01
3 UC BERKELEY 338 125.90
4 KAISER FOUNDATION 73 62.45
5 SRI INTERNATIONAL 83 51.70
6 J. D. GLADSTONE INST. 53 32.74
7 NORTHERN CA INST. 47 27.09
8 LAWRENC BERKELEY LAB 35 22.01
9 PALO ALTO VET. INST. 32 12.61
10 PUBLIC HEALTH INST. 20 11.28
3/22/2017
7
Top Funding Recipients
8. C 2017 SoCalBio
TOP SAN FRANCISCO BAY AREA INVESTIGATORS, BY THE
AMOUNT OF 2016 NIH FUNDING
3/22/2017
8
NAME:
GRANDIS,
JENNIFER
WHITMER,
RACHEL
HAVLIR, DIANE
GREENBERG,
HARRY
ASHWORTH,
ALAN
AFFILIATION: UCSF
KAISER
FOUNDATION
UCSF
STANFORD
UNIVERSITY
UCSF
# AWARDS: 4 2 3 6 9
FUNDIG
$MILLION:
$19.82 $13.68 $12.39 $10.99 $8.78
FUNDING
FOCUS:
HEAD AND
NICK CANCER &
TRANSLATIONAL
SCIENCE
COGNITIVE
HEALTH
AIDS, MALARIA
AND
ANTIRETROVIRAL
THERAPY
IMMUNITY AND
TRANSLATIONAL
RESEARCH
EDUCATIOM
CANCER
CENTER
SUPPORT
1 432 5
9. C 2017 SoCalBio
GREATER LOS ANGELES ORGANIZATIONS THAT WON
NIH GRANTS IN 2016
3/22/2017
9
ORGANIZATION AWARDS
FUNDING
$Million
1 UCLA 836 381.047
2 USC 411 212.11
3 UCI 301 111.86
4 CALTECH 134 63.09
5 CEDARS-SINAI 107 47.45
6 CITY OF HOPE 91 42.05
7 RAND CORP. 56 26.08
8 UCR 66 20.35
9
CHILDREN'S
HOSPITAL OF LOS
ANGELES
41 20.24
10 UCSB 53 18.29
Top Funding Recipients
10. C 2017 SoCalBio
TOP GREATER LOS ANGELES INVESTIGATORS, BY THE
AMOUNT OF 2016 NIH FUNDING
3/22/2017
10
NAME:
MITSUYASU,
RONALD
DUBINETT,
STEVEN
BUCHANAN,
THOMAS
ROTHERAM-
BORUS,
MARY JANE
STERNBERG,
PAUL
AFFILIATION: UCLA UCLA USC UCLA CALTECH
# AWARDS: 1 2 1 8 4
FUNDING
$MILLION:
$21.62 $17.51 $9.56 $7.79 $7.23
FUNDING
FOCUS:
AIDS
LUNG
CANCER
CLINICAL &
TRANSLATIO
NAL
RESEARCH
AIDS & DRUG
OF ABUSE
SYSTEM
BIOLOGY OF
NEMATODES
1 432 5
11. C 2017 SoCalBio
SAN DIEGO COUNTY ORGANIZATIONS THAT WON NIH
GRANTS IN 2016
ORGANIZATION AWARDS
FUNDING
$Million
1 UCSD 835 $400.87
2 SCRIPPS 288 $213.69
3
SANFORD
BURNHAM INST
109 $54.24
4 SALK INSTITUTE 65 $32.59
5 LA JOLLA INST 54 $31.70
6
SAN DIEGO STATE
UNIV.
60 $24.60
7 LUDWIG INSTITUTE 22 $9.40
8
VETERANS MEDICAL
RESEARCH FDN/SAN
DIEGO
17 $7.60
3/22/2017
11
Top Funding Recipients
12. C 2017 SoCalBio
TOP SAN DIEGO COUNTY INVESTIGATORS, BY THE
AMOUNT OF 2016 NIH FUNDING
NAME: TOPOL, ERIC
BURTON,
DENNIS
FELDMAN,
HOWARD
FIRESTEIN,
GARY
ULEVITCH,
RICHARD
AFFILIATION: SCRIPPS SCRIPPS UCSD UCSD SCRIPPS
# AWARDS: 5 4 5 3 1
FUNDIG
$MILLION:
$42,499,376 $29,321,475 $10,470,025 $9,111,956 $8,033,507
FUNDING
FOCUS
DIGITAL HEALTH
&
TRANSLATIONAL
SCIENCE
AIDS ALZHEIMERS
INFLAMMATION
& CLINICAL AND
TRANSLATIONAL
RESEARCH
IMMUNITY &
INFLAMMATION
3/22/2017
12
1 432 5
13. C 2017 SoCalBio
DEEP CUTS IN NIH FUNDING PUT HEALTH RESEARCH AND
PATIENT WELFARE AT RISK
? The NIH controls more than 50 percent of all funding for health research,
and 85 percent of all funding for health studies in universities.
? The proposed 20% cut in the NIH budget may negatively impact, not just
life-science research throughout California and elsewhere, but also
patients who are waiting for treatments based on this research.
? Numerous studies have documented the direct and indirect benefits of
public funding of medical research to develop life-saving drugs and
extend life expectancy.
? For example, a 2001 National Bureau of Economic Research (NBER) study
found that of the 21 drugs with the highest therapeutic impact on society
introduced between 1965 and 1992, 14 resulted from key enabling
discoveries funded by public research.
? According to Dr. Randy Hall, Vice Provost for Research at USC, Public
spending on health research have resulted in health improvement and
increased life expectancy by 10% during the last five decades in the US.
? The social value of increases in longevity and health improvements
totaled $95 trillion between 1970 and 2000, according to Research by the
University of Chicago and NBER.
? Steep cuts in NIH Funding may endanger some of these advances.
3/22/2017
13
14. C 2017 SoCalBio
BIOSCIENCE JOBS MAY ALSO BE AT RISK
? NIH funding supports bioscience job creation and industry growth
across the country, and California is no different. Cuts in NIH budget
may therefore result in:
? Fewer job opportunities for college graduates and budding PhDs to start
their careers in academia and industry
? NIH-dependent research institutions, such as the USC Keck School of
Medicine in Los Angeles which receives more than 60 percent of its
research funding from competitive NIH grants, are likely to see
significant cuts in research and staffing.
? USC expects 250 researchers to be laid off, if the proposed Trump cuts take
effect.
? These cuts also mean less funding options for bioscience startups
due to expected cuts in SBIR/STTR grant allocations.
? In 2016, 266 California-based emerging bioscience companies were
awarded SBIRs/STTRs totaling $176 million.
? SBIR funding has served as a life boat enabling such emerging companies to
cross the financial valley of death, raise capital and grow.
? Cuts in such funding may negatively impact startup growth prospects and
job creation.
3/22/2017
14
15. C 2017 SoCalBio
On April 4 & 5, 2017, SoCalBio will join other bioscience
trade associations and hundreds of biotech executives to
meet with legislators in the U.S. Congress during the BIO
Legislative Day in Washington, D.C. The mission of this
legislative day is to advocate for sustaining, if not
increasing, NIH funding and educate law-makers about
The Value of Innovation.
3/22/2017
15
16. C 2017 SoCalBio
ABOUT SOCALBIO
? Southern California Biomedical Council
(SoCalBio) is a nonprofit, member-
supported trade association that serves the
biotech, medtech, IVD and digital health
communities in the six counties that
comprise the Greater Los Angeles region
(Los Angeles, Orange, Ventura, Santa
Barbara, Riverside and San Bernardino).
? SoCalBios programs help local firms gain
access to capital, potential partners and
other business services. The Council also
promotes technology transfer and
workforce training, while informing policy
makers and the public at-large about the
benefits of the regions bioscience industry.
3/22/2017
16
17. 17
Thank You
Ahmed A. Enany
enany@socalbio.org
Southern California Biomedical Council
Your Success Is Our Business
www.socalbio.org
617 S. Olive St., Ste. 700, Los Angeles, CA 90014
Phn: 800-418-7079 -- Fax: 213-622-7100 -- scbc@socalbio.org